Patents by Inventor Chang Ho Kang

Chang Ho Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11857580
    Abstract: The present invention relates to a Lactobacillus strain having antimicrobial activity against Gardnerella vaginalis and Candida albicans, a culture medium of the strain, and a cell-free supernatant of the strain, and to an antimicrobial composition containing the same, a pharmaceutical composition for preventing or treating Gardnerella vaginalis infection or Candida albicans infection containing the same, a pharmaceutical composition for prevention or treatment of vaginitis containing the same, a health functional food for prevention or ameliorating of vaginitis containing the same, and a quasi-drug composition for prevention or amelioration of vaginitis containing the same.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: January 2, 2024
    Assignee: Mediogen Co., Ltd.
    Inventors: Nam-Soo Paek, Chang Ho Kang
  • Publication number: 20230414684
    Abstract: Provided is a composition for preventing or treating colorectal cancer including a mixed strain of probiotics as an active ingredient, specifically, a composition for preventing, alleviating or treating colorectal cancer including a mixed killed strain of L. casei, L. reuteri or Bi. bifidum. According to the present disclosure, the composition is confirmed to have excellent effects of activating apoptosis-related signaling molecules in colorectal cancer cells and inhibiting the growth of tumors derived from colorectal cancer cells, and thus may be usefully used in various industrial fields such as medicines and foods, for prevention, alleviation, or treatment of colorectal cancer.
    Type: Application
    Filed: May 3, 2023
    Publication date: December 28, 2023
    Inventors: Nam Soo Paek, Chang Ho Kang
  • Publication number: 20230374534
    Abstract: A transgenic plant having cold resistance overexpressing thioredoxin Trx-h2 protein. More specifically, the present invention relates to a transgenic plant having cold resistance overexpressing thioredoxin Trx-h2 protein which is an interacting partner of cold-responsive C-repeat-binding transcription factors (CBF 1).
    Type: Application
    Filed: September 9, 2021
    Publication date: November 23, 2023
    Inventors: Sang Yeol LEE, Eun Seon LEE, Joung Hun PARK, Seong Dong WI, Chang Ho KANG, Ho Byoung CHAE, Seol Ki PAENG, Su Bin BAE
  • Patent number: 11767390
    Abstract: The present disclosure relates to a UV-curable resin composition enabling thermoforming and a replica film of a real material including the same, in which the UV-curable resin composition includes a prepolymer including a urethane-based oligomer and an acrylic oligomer, an acrylate monomer and a photoinitiator.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: September 26, 2023
    Assignees: HYUNDAI MOTOR COMPANY, KIA MOTORS CORPORATION, SKC HI-TECH & MARKETING CO., LTD.
    Inventors: Jae Sik Seo, Hyun Jung Kim, Hyun Kyung Kwon, Seong Do Kim, Chang Ho Kang
  • Patent number: 11738057
    Abstract: Disclosed is a Lactobacillus strain having a blood glucose lowering effect and an antioxidant effect, a culture medium of the strain, and a cell-free supernatant of the strain. Further, a composition for lowering a blood glucose level contains the same. A composition having an antioxidant ability contains the same. The Lactobacillus plantarum MG4229 strain according to the present disclosure has excellent blood glucose lowering activity and antioxidant activity, and has excellent acid tolerance, bile tolerance, auto-aggregation, and adhesion to epithelial cells, and thus is suitable for probiotics, and thus may be used in various ways as a composition for preventing or treating diabetes mellitus or a composition having antioxidant ability.
    Type: Grant
    Filed: July 22, 2020
    Date of Patent: August 29, 2023
    Assignee: Mediogen Co., Ltd.
    Inventors: Nam-Soo Paek, Chang Ho Kang
  • Patent number: 11680129
    Abstract: Disclosed are a UV-curable resin composition for vacuum forming and a replica film of a real material including the same. The UV-curable resin composition includes a prepolymer including a urethane-containing oligomer, an acrylate monomer and a photoinitiator.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: June 20, 2023
    Assignees: Hyundai Motor Company, Kia Motors Corporation, SKC Hi-Tech & Marketing Co., Ltd.
    Inventors: Jae Sik Seo, Hyun Jung Kim, Hyun Kyung Kwon, Seong Do Kim, Chang Ho Kang
  • Publication number: 20230158087
    Abstract: Provided are a Lactobacillus helveticus strain and a composition for preventing or treating inflammatory disease containing the same. The Lactobacillus helveticus strain (Accession No. KCTC 14110BP) according to the present invention alleviates symptoms of inflammatory bowel disease, such as weight loss and bowel length reduction, and it does not have side effects that have been seen with existing drug treatment. Therefore, the Lactobacillus helveticus strain can be effectively used for the treatment and prevention of inflammatory disease, particularly inflammatory bowel disease.
    Type: Application
    Filed: February 25, 2021
    Publication date: May 25, 2023
    Inventors: Bo Gie YANG, Myung Ho JANG, Chang Ho KANG, Nam Soo PAEK
  • Publication number: 20230111353
    Abstract: Provided is a novel Lactobacillus Plantarum strain and a composition for preventing or treating a metabolic disease including the same. A Lactobacillus Plantarum (Accession No. KCTC 14107BP) according to the present invention may inhibit fat accumulation in white adipose tissue, brown adipose tissue, and liver tissue. The Lactobacillus Plantarum strain may exhibit excellent blood glucose improvement effect, and in particular, may reduce a fasting blood glucose level. The Lactobacillus Plantarum strain may effectively ameliorate insulin resistance by improving glucose tolerance and increasing insulin sensitivity. In addition, the Lactobacillus Plantarum strain may regulate a concentration of metabolic hormones in blood. Therefore, the Lactobacillus Plantarum strain may be usefully used to prevent or treat a metabolic disease.
    Type: Application
    Filed: December 29, 2020
    Publication date: April 13, 2023
    Inventors: Bo Gie YANG, Myung Ho JANG, Chang Ho KANG, Nam Soo PAEK
  • Publication number: 20230038910
    Abstract: Provided is a novel Lactobacillus fermentum strain (Accession No. KCTC 14106BP) and a composition for preventing or treating a metabolic disease including the same. A Lactobacillus fermentum according to the present invention may inhibit fat accumulation and increase anti-inflammatory cells in white adipose tissue. In addition, the Lactobacillus fermentum may effectively inhibit fat accumulation in brown adipose tissue and in liver tissue. The Lactobacillus fermentum strain may exhibit excellent blood glucose improvement effect, and in particular, may reduce a fasting blood glucose level. The Lactobacillus fermentum strain may effectively ameliorate insulin resistance by improving glucose tolerance and increasing insulin sensitivity. Therefore, the Lactobacillus fermentum strain may be usefully used to prevent or treat a metabolic disease such as obesity.
    Type: Application
    Filed: December 29, 2020
    Publication date: February 9, 2023
    Inventors: Bo Gie YANG, Myung Ho JANG, Chang Ho KANG, Nam Soo PAEK
  • Publication number: 20230012950
    Abstract: There is provided a novel Lactobacillus fermentum strain (Accession No. KCTC 14105BP) and a composition for preventing or treating a metabolic disease including the same. A Lactobacillus fermentum according to the present invention may inhibit fat accumulation in white adipose tissue and increase anti-inflammatory cells. The Lactobacillus fermentum strain may exhibit excellent blood glucose improvement effect, and in particular, may reduce a fasting blood glucose level. The Lactobacillus fermentum strain may effectively ameliorate insulin resistance by improving glucose tolerance and increasing insulin sensitivity. In addition, the Lactobacillus fermentum strain may regulate a concentration of metabolic hormones and adipokines in blood. Therefore, the Lactobacillus fermentum strain may be usefully used to prevent and treat a metabolic disease such as obesity.
    Type: Application
    Filed: December 29, 2020
    Publication date: January 19, 2023
    Inventors: Bo Gie YANG, Myung Ho JANG, Chang Ho KANG, Nam Soo PAEK
  • Patent number: 11484557
    Abstract: The present invention relates to: human-derived Lactobacillus fermentum MG4231 or Lactobacillus fermentum MG4244; and a pharmaceutical composition, a food composition, a quasi-drug composition and a health functional food for preventing or treating obesity-related diseases, all of which include the same as an active ingredient. A Lactobacillus fermentum MG4231 strain or MG4244 strain of the present invention exhibits an anti-obesity activity for inhibiting a lipase enzyme activity, inhibiting preadipocyte differentiation and inhibiting triglyceride accumulation, has an excellent ability to form colonies on the epithelial cells of a digestive tract by means of an excellent auto-aggregation ability, and has resistance to acid and bile, thereby being variously usable as a pharmaceutical composition, a food composition, a quasi-drug composition and a health functional food for the purpose of treating and preventing obesity-related diseases.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: November 1, 2022
    Assignee: Mediogen Co., Ltd.
    Inventors: Nam Soo Paek, Chang Ho Kang
  • Patent number: 11220129
    Abstract: The present invention relates to a decoration sheet to be applied to an exterior material for electric home appliances or electronic devices. The decoration sheet includes a pattern layer having lenticular lenses arranged in multiple rows, wherein at least one of the multiple rows has one or more discontinuous lens sections in which the lenticular lens is not continuous, thereby reducing poor visibility and enhancing productivity; and the discontinuous lens sections can be arranged to implement a character, a pattern, or the like, thereby expressing a sense of pattern. Further, the decoration sheet has an adhesive layer formed on the other surface thereof and thus can function to prevent the scattering of a surface of glass or the like onto which the decoration sheet is attached.
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: January 11, 2022
    Assignee: SKC HI-TECH & MARKETING CO., LTD.
    Inventors: Hee-Young Lim, Sang-Hyun Park, Chang-Ho Kang, Seong Do Kim, Hyun Kyung Kwon, Hyung Joon Paik
  • Publication number: 20210388146
    Abstract: Disclosed are a UV-curable resin composition for vacuum forming and a replica film of a real material including the same. The UV-curable resin composition includes a prepolymer including a urethane-containing oligomer, an acrylate monomer and a photoinitiator.
    Type: Application
    Filed: November 30, 2020
    Publication date: December 16, 2021
    Inventors: Jae Sik Seo, Hyun Jung Kim, Hyun Kyung Kwon, Seong Do Kim, Chang Ho Kang
  • Publication number: 20210322493
    Abstract: The present invention relates to: human-derived Lactobacillus fermentum MG4231 or Lactobacillus fermentum MG4244; and a pharmaceutical composition, a food composition, a quasi-drug composition and a health functional food for preventing or treating obesity-related diseases, all of which include the same as an active ingredient. A Lactobacillus fermentum MG4231 strain or MG4244 strain of the present invention exhibits an anti-obesity activity for inhibiting a lipase enzyme activity, inhibiting preadipocyte differentiation and inhibiting triglyceride accumulation, has an excellent ability to form colonies on the epithelial cells of a digestive tract by means of an excellent auto-aggregation ability, and has resistance to acid and bile, thereby being variously usable as a pharmaceutical composition, a food composition, a quasi-drug composition and a health functional food for the purpose of treating and preventing obesity-related diseases.
    Type: Application
    Filed: August 27, 2019
    Publication date: October 21, 2021
    Inventors: Nam Soo Paek, Chang Ho Kang
  • Publication number: 20210115178
    Abstract: The present disclosure relates to a UV-curable resin composition enabling thermoforming and a replica film of a real material including the same, in which the UV-curable resin composition includes a prepolymer including a urethane-based oligomer and an acrylic oligomer, an acrylate monomer and a photoinitiator.
    Type: Application
    Filed: September 29, 2020
    Publication date: April 22, 2021
    Inventors: Jae Sik Seo, Hyun Jung Kim, Hyun Kyung Kwon, Seong Do Kim, Chang Ho Kang
  • Publication number: 20210023147
    Abstract: Disclosed is a Lactobacillus strain having a blood glucose lowering effect and an antioxidant effect, a culture medium of the strain, and a cell-free supernatant of the strain. Further, a composition for lowering a blood glucose level contains the same. A composition having an antioxidant ability contains the same. The Lactobacillus plantarum MG4229 strain according to the present disclosure has excellent blood glucose lowering activity and antioxidant activity, and has excellent acid tolerance, bile tolerance, auto-aggregation, and adhesion to epithelial cells, and thus is suitable for probiotics, and thus may be used in various ways as a composition for preventing or treating diabetes mellitus or a composition having antioxidant ability.
    Type: Application
    Filed: July 22, 2020
    Publication date: January 28, 2021
    Inventors: Nam-Soo Paek, Chang Ho Kang
  • Publication number: 20200345798
    Abstract: The present invention relates to a lactobacillus strain having antimicrobial activity against Gardnerella vaginalis and Candida albicans, a culture medium of the strain, and a cell-free supernatant of the strain, and to a antimicrobial composition containing the same, a pharmaceutical composition for preventing or treating Gardnerella vaginalis infection or Candida albicans infection containing the same, a pharmaceutical composition for prevention or treatment of vaginitis containing the same, a health functional food for prevention or ameliorating of vaginitis containing the same, and a quasi-drug composition for prevention or ameliorating of vaginitis containing the same.
    Type: Application
    Filed: April 16, 2020
    Publication date: November 5, 2020
    Inventors: Nam-Soo Paek, Chang Ho Kang
  • Publication number: 20200069748
    Abstract: The present invention relates to human-derived Lactobacillus fermentum MG4231 or Lactobacillus fermentum MG4244 and to a pharmaceutical composition for the prevention or treatment of obesity-related diseases, containing the same as an active ingredient, and a food composition, quasi-drug composition and functional health food. The Lactobacillus fermentum MG4231 strain or MG4244 strain of the present invention exhibits anti-obesity activity that inhibits lipase enzyme activity, preadipocyte differentiation and neutral lipid accumulation, has high autoaggregation ability to thus show excellent colony formation ability on the epithelial cells of the digestive tract, and is resistant to acid and bile. Thereby, the Lactobacillus fermentum MG4231 strain or the MG4244 strain can be variously utilized in a pharmaceutical composition for the prevention and treatment of obesity-related diseases, and a food composition, quasi-drug composition and functional health food.
    Type: Application
    Filed: September 30, 2019
    Publication date: March 5, 2020
    Inventors: Nam Soo PAEK, Chang Ho KANG
  • Publication number: 20190337325
    Abstract: The present invention relates to a decoration sheet to be applied to an exterior material for electric home appliances or electronic devices. The decoration sheet includes a pattern layer having lenticular lenses arranged in multiple rows, wherein at least one of the multiple rows has one or more discontinuous lens sections in which the lenticular lens is not continuous, thereby reducing poor visibility and enhancing productivity; and the discontinuous lens sections can be arranged to implement a character, a pattern, or the like, thereby expressing a sense of pattern. Further, the decoration sheet has an adhesive layer formed on the other surface thereof and thus can function to prevent the scattering of a surface of glass or the like onto which the decoration sheet is attached.
    Type: Application
    Filed: January 25, 2017
    Publication date: November 7, 2019
    Applicant: SKC HI-TECH & MARKETING CO., LTD.
    Inventors: Hee-Young LIM, Sang-Hyun PARK, Chang-Ho KANG, Seong Do KIM, Hyun Kyung KWON, Hyung Joon PAIK
  • Patent number: 9157599
    Abstract: Disclosed is an LED lighting system comprising a housing equipped with a transparent substrate as an illuminating side, an LED light source located in the housing, and a haze-changeable film attached to the transparent substrate, wherein the transparency of the haze-changeable film changes depending on the application of electric power and the haze-changeable film has a haze on light varying with the intensity of an applied voltage/current. The LED lighting system may be useful for interior emotional lighting because a direct/indirect lighting and a mixed lighting thereof can be provided with a single system and various correlated color temperatures can be produced with a single LED light source.
    Type: Grant
    Filed: February 9, 2013
    Date of Patent: October 13, 2015
    Assignee: SKC DISPLAY FILMS CO., LTD.
    Inventors: Hyun Seok Cho, Hyung Joon Paik, Hyo Gil Cha, Chang Ho Kang, Hyun Cheol Nam